- Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation
-
Agarwal R, Koenig K, Rohren E, Subbiah V
- KMID: 2286357
- J Breast Cancer.
- 2014 Sep;17(3):287-290.
- doi: 10.4048/jbc.2014.17.3.287
Metaplastic breast cancer (MpBC) is an extremely rare breast cancer subtype, characterized by a heterogeneous phenotype. MpBC aggressive biology is attributed to its stem cell-like characteristics. Since these tumors are... -
- CITED
-
- Close
- SHARE
-
- Close
